Home › NCT03825809

Nonopioid Analgesia After Labral Surgery

Traditional vs. Nonopioid Analgesia After Labral Surgery

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Eligibility Criteria:

Inclusion Criteria:

* All adult patients over age 18 and scheduled for a primary or revision labral surgery

Exclusion Criteria:

* Exclusion criteria will include patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin, dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding. Secondary exclusion criterion is an intact rotator cuff

About the study

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

What is being tested

• Celecoxib (drug)
• Hydrocodone-Acetaminophen (drug)
• Ketorolac (drug)
• Gabapentin (drug)
• Acetaminophen (drug)
• Diazepam (drug)

Sponsor: Henry Ford Health System · Participants: 100 · Started: Jan 22, 2019

Contact the study team

• Toufic R Jildeh, MD · Phone: 517-230-8511

Official record on ClinicalTrials.gov — NCT03825809

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.